39% OF OZEMPIC USERS SAY THEIR FINGERNAILS ARE FALLING OFF

Researchers surveyed 575 people on GLP-1 drugs against 1,329 people with type 2 diabetes or obesity who had never taken them, recruited across France, the US, Brazil and Mexico, then presented it at the European Academy of Dermatology and Venereology congress in Vienna. Result: 39% of users reported onycholysis, the medical term for your fingernail resigning from your finger. Controls came in at 9%. Nail discoloration ran 46% versus 17%, and two thirds of users reported at least one nail disorder. The companion hair study is worse. Unusual shedding in 50% of users versus 34% of controls, lost density or volume in 42% versus 19%, and scalp redness about three times more common. Smaller pants, thinner hair, nails sold separately. Now the part the headlines keep sprinting past. All of this is self-reported at a single point in time, with no dermatologist ever looking at anyone's hands. About half the GLP-1 group already had nail trouble before they started, and when the team isolated brand new damage, the gap largely collapsed. The study author said it plainly: not everything that happens during GLP-1 treatment is caused by the treatment. Crash weight loss and thin intake of protein, iron and zinc wreck nails and hair all on their own, and they don't cost $1,000 a month.

Why you should give a shit: Nobody has run the proper study yet, so until they do, the move isn't quitting the drug over your cuticles, it's eating actual protein like a grown man instead of three bites of chicken and a nap.